DEEP IMMERSION FLOTATION THERAPY FOR BURN VICTIMS
This invention provides compositions for and methods of treating burn wounds in a subject.
1 . A method of treating a burn injury of a subject comprising immersing the subject in a liquid composition comprising an oxygenated perfluorocarbon so as to thereby treat the burn injury.
2 . A method of treating a burn injury of a subject's skin comprising immersing the skin burn injury in a liquid composition comprising an oxygenated perfluorocarbon so as to thereby treat the skin burn injury.
3 . A method of reducing skin scarring associated with a skin burn injury in a subject comprising immersing the skin burn injury in a liquid composition comprising an oxygenated perfluorocarbon so as to thereby treat the skin burn injury and thereby reduce the skin scarring.
4 . The method of claim 1 , wherein the subject is partially immersed in the liquid composition.
5 . The method of claim 1 , wherein the subject is fully immersed in the liquid composition.
6 . The method of claim 5 , wherein the subject is artificially ventilated via intubation.
7 . (canceled)
8 . (canceled)
9 . The method of claim 1 , wherein the liquid composition is located in a container and is mechanically circulated.
10 . The method of claim 9 , wherein the liquid composition is filtered.
11 . The method of claim 1 , wherein the liquid composition is at body temperature.
12 . The method of claim 1 , wherein the liquid composition is cooled below ambient temperature.
13 . The method of claim 1 , wherein the liquid composition is heated above ambient temperature.
14 . The method of claim 1 , wherein the liquid composition is a pharmaceutical composition and comprises a pharmaceutically acceptable carrier.
15 . The method of claim 1 , wherein the liquid composition is a perflurocarbon emulsion.
16 . The method of claim 15 , wherein the perfluorocarbon emulsion has a particle size of about 0.3 microns or less.
17 . The method of claim 15 , wherein the perfluorocarbon emulsion has a particle size of about 0.05 to 0.1 microns.
18 . The method of claim 1 , wherein the liquid composition is bubbled with 1%-100% oxygen.
19 . The method of claim 18 , wherein the composition is bubbled with 100% oxygen.
20 . The method of claim 1 , wherein the composition further comprises a topical anesthetic.
21 . The method of claim 1 , wherein the composition further comprises an antibacterial agent.
22 . The method of claim 1 , wherein the perfluorocarbon is perfluoro-tert-butylcyclohexane.
23 . The method of claim 1 , wherein the subject is human.
24 - 32 . (canceled)